loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 205513 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CARISOPRODOL (2)

filter

01 STRIDES PHARMA (2)

filter

01 TABLET;ORAL (2)

filter

01 250MG (1)

02 350MG (1)

filter

01 USA (2)

TABLET;ORAL
350MG
CARISOPRODOL
USA
205513
2015-11-12
DISCN
TABLET;ORAL
250MG
CARISOPRODOL
USA
205513
2015-11-12
DISCN

Looking for CTD TGA MCC DOSSIER APPLICATION 205513

Looking for CTD TGA MCC DOSSIER APPLICATION 205513 2

19

Strides Pharma Science, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

One of their notable products is CARISOPRODOL, with a corresponding application number 205513 and regulatory information .

proudly manufactured in the

approval since 2015-11-12

Strides Pharma Science's CARISOPRODOL TABLET;ORAL, medication with 350MG of CARISOPRODOL.

18

Strides Pharma Science, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

One of their notable products is CARISOPRODOL, with a corresponding application number 205513 and regulatory information .

proudly manufactured in the

approval since 2015-11-12

Strides Pharma Science's CARISOPRODOL TABLET;ORAL, medication with 250MG of CARISOPRODOL.

Post Enquiry
POST ENQUIRY